LI
DFTX

Louisbourg Investments’s Definium Therapeutics DFTX Stock Holding History

Louisbourg Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52
Closed -$983 – 222
2026
Q1 		$983 Buy
+52
New +$882 ﹤0.01% 203
2025
Q4 		– Sell
-52
Closed -$613 – 220
2025
Q3 		$613 Hold
52
– – ﹤0.01% 196
2025
Q2 		$337 Hold
52
– – ﹤0.01% 194
2025
Q1 		$304 Hold
52
– – ﹤0.01% 174
2024
Q4 		$362 Hold
52
– – ﹤0.01% 162
2024
Q3 		$296 Hold
52
– – ﹤0.01% 167
2024
Q2 		$375 Hold
52
– – ﹤0.01% 162
2024
Q1 		$492 Hold
52
– – ﹤0.01% 158
2023
Q4 		$190 Buy
+52
New +$157 ﹤0.01% 160

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Louisbourg Investments's DFTX Position: Q2 2026 in Review

Louisbourg Investments sold out of Definium Therapeutics (DFTX) in Q2 2026, closing a stake of 52 shares — an estimated $983 sold.

Louisbourg Investments first reported a position in DFTX in Q4 2023 and held it in 9 quarters. The position peaked at $983 in Q1 2026. 142 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • Louisbourg Investments reported no remaining Definium Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Louisbourg Investments sold 52 Definium Therapeutics shares in Q2 2026, an estimated $983.
  • Louisbourg Investments first reported a position in Definium Therapeutics in Q4 2023 and held it in 9 quarters.
  • Louisbourg Investments's Definium Therapeutics position peaked at $983 in Q1 2026.
  • 142 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Louisbourg Investments's 13F filing for Q2 2026, filed 23 Jul 2026.